EdgarLookup

FLEX LTD. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that FLEX LTD. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
3.2%
Profit Margin
Net income ÷ revenue
1.2%
Return on Assets
Net income ÷ assets
2.67x
Debt-to-Equity
Total liabilities ÷ equity
-12.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2010 Mar 31, 2011 $6.86B May 23, 2011
FY2010 Dec 31, 2010 $7.83B May 23, 2011
FY2010 Oct 1, 2010 $7.42B May 23, 2011
FY2010 Jul 2, 2010 $6.57B May 23, 2011
FY2010 Mar 31, 2010 $5.94B May 23, 2011
FY2010 Dec 31, 2009 $6.56B May 23, 2011
FY2010 Oct 2, 2009 $5.83B May 23, 2011
FY2010 Jul 3, 2009 $5.78B May 23, 2011
FY2009 Mar 31, 2009 $30.95B May 24, 2010
FY2009 Mar 31, 2008 $27.56B May 24, 2010

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $6.40B May 21, 2025
FY2025 Dec 31, 2024 $6.56B May 21, 2025
FY2025 Sep 27, 2024 $6.55B May 21, 2025
FY2025 Jun 28, 2024 $6.31B May 21, 2025
FY2025 Mar 31, 2024 $6.17B May 21, 2025
FY2025 Dec 31, 2023 $6.42B May 21, 2025
FY2025 Sep 29, 2023 $6.93B May 21, 2025
FY2025 Jun 30, 2023 $6.89B May 21, 2025
FY2024 Mar 31, 2023 $6.98B May 17, 2024
FY2024 Dec 31, 2022 $7.25B May 17, 2024

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Mar 31, 2018 $6.41B Jun 14, 2018
FY2018 Dec 31, 2017 $6.75B Jun 14, 2018
FY2018 Sep 29, 2017 $6.27B Jun 14, 2018
FY2018 Jun 30, 2017 $6.01B Jun 14, 2018
FY2018 Mar 31, 2017 $5.86B Jun 14, 2018
FY2018 Dec 31, 2016 $6.11B Jun 14, 2018
FY2018 Sep 30, 2016 $6.01B Jun 14, 2018
FY2018 Jul 1, 2016 $5.88B Jun 14, 2018
FY2017 Mar 31, 2016 $5.77B May 16, 2017
FY2017 Dec 31, 2015 $6.76B May 16, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $222.00M May 21, 2025
FY2025 Dec 31, 2024 $263.00M May 21, 2025
FY2025 Sep 27, 2024 $214.00M May 21, 2025
FY2025 Jun 28, 2024 $139.00M May 21, 2025
FY2025 Mar 31, 2024 $395.00M May 21, 2025
FY2025 Dec 31, 2023 $197.00M May 21, 2025
FY2025 Sep 29, 2023 $228.00M May 21, 2025
FY2025 Jun 30, 2023 $186.00M May 21, 2025
FY2024 Mar 31, 2023 $142.00M May 17, 2024
FY2024 Dec 31, 2022 $230.00M May 17, 2024

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $305.00M May 21, 2025
FY2025 Dec 31, 2024 $334.00M May 21, 2025
FY2025 Sep 27, 2024 $297.00M May 21, 2025
FY2025 Jun 28, 2024 $233.00M May 21, 2025
FY2025 Mar 31, 2024 $159.00M May 21, 2025
FY2025 Dec 31, 2023 $198.00M May 21, 2025
FY2025 Sep 29, 2023 $281.00M May 21, 2025
FY2025 Jun 30, 2023 $215.00M May 21, 2025
FY2024 Mar 31, 2023 $223.00M May 17, 2024
FY2024 Dec 31, 2022 $259.00M May 17, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $18.38B May 21, 2025
FY2025 Mar 31, 2024 $18.26B May 21, 2025
FY2024 Mar 31, 2023 $21.41B May 17, 2024
FY2023 Mar 31, 2022 $19.33B May 19, 2023
FY2022 Mar 31, 2021 $15.84B May 20, 2022
FY2021 Mar 31, 2020 $13.69B May 19, 2021
FY2020 Mar 31, 2019 $13.50B May 28, 2020
FY2019 Mar 31, 2018 $13.72B May 21, 2019
FY2018 Mar 31, 2017 $12.59B Jun 14, 2018
FY2017 Mar 31, 2016 $12.38B May 16, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $13.38B May 21, 2025
FY2025 Mar 31, 2024 $12.93B May 21, 2025
FY2024 Mar 31, 2023 $15.70B May 17, 2024
FY2023 Mar 31, 2022 $15.12B May 19, 2023
FY2022 Mar 31, 2021 $12.40B May 20, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $5.00B May 21, 2025
FY2025 Mar 31, 2024 $5.33B May 21, 2025
FY2024 Mar 31, 2023 $5.35B May 17, 2024
FY2023 Mar 31, 2022 $4.13B May 19, 2023
FY2018 Mar 31, 2018 $3.02B Jun 14, 2018
FY2018 Mar 31, 2017 $2.64B Jun 14, 2018
FY2017 Mar 31, 2016 $2.57B May 16, 2017
FY2016 Mar 31, 2015 $2.36B May 20, 2016
FY2015 Mar 31, 2014 $2.16B May 21, 2015
FY2013 Mar 31, 2013 $2.25B May 20, 2014

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 0 May 21, 2025
FY2025 Dec 31, 2024 0 May 21, 2025
FY2025 Sep 27, 2024 0 May 21, 2025
FY2025 Jun 28, 2024 0 May 21, 2025
FY2025 Mar 31, 2024 0 May 21, 2025
FY2025 Dec 31, 2023 0 May 21, 2025
FY2025 Sep 29, 2023 0 May 21, 2025
FY2025 Jun 30, 2023 0 May 21, 2025
FY2024 Mar 31, 2023 0 May 17, 2024
FY2024 Dec 31, 2022 0 May 17, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 0 May 21, 2025
FY2025 Dec 31, 2024 0 May 21, 2025
FY2025 Sep 27, 2024 0 May 21, 2025
FY2025 Jun 28, 2024 0 May 21, 2025
FY2025 Mar 31, 2024 0 May 21, 2025
FY2025 Dec 31, 2023 0 May 21, 2025
FY2025 Sep 29, 2023 0 May 21, 2025
FY2025 Jun 30, 2023 0 May 21, 2025
FY2024 Mar 31, 2023 0 May 17, 2024
FY2024 Dec 31, 2022 0 May 17, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $2.29B May 21, 2025
FY2025 Mar 31, 2024 $2.47B May 21, 2025
FY2024 Mar 31, 2023 $3.16B May 17, 2024
FY2023 Mar 31, 2022 $2.96B May 19, 2023
FY2022 Mar 31, 2021 $2.64B May 20, 2022
FY2021 Mar 31, 2020 $1.92B May 19, 2021
FY2020 Mar 31, 2019 $1.70B May 28, 2020
FY2019 Mar 31, 2018 $1.47B May 21, 2019
FY2018 Mar 31, 2017 $1.83B Jun 14, 2018
FY2018 Mar 31, 2016 $1.61B Jun 14, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $3.69B May 21, 2025
FY2025 Mar 31, 2024 $3.26B May 21, 2025
FY2024 Mar 31, 2023 $3.69B May 17, 2024
FY2023 Mar 31, 2022 $4.20B May 19, 2023
FY2021 Mar 31, 2021 $3.80B May 19, 2021
FY2020 Mar 31, 2020 $2.85B May 28, 2020
FY2019 Mar 31, 2019 $3.07B May 21, 2019
FY2018 Mar 31, 2018 $2.95B Jun 14, 2018
FY2017 Mar 31, 2017 $2.97B May 16, 2017
FY2016 Mar 31, 2016 $2.79B May 20, 2016